Virax Biolabs files initial beneficial ownership statement for Chief Scientific Officer Clement Monteil
VRAX•Virax Biolabs Chief Scientific Officer Clement Monteil disclosed stock options covering 4,860 ordinary shares in an initial beneficial ownership statement.
1. Ownership disclosure
Virax Biolabs Chief Scientific Officer Clement Monteil disclosed stock options covering 4,860 ordinary shares in an initial beneficial ownership statement.
